Journal of Emergency Practice and Trauma

Posterior reversible encephalopathy syndrome due to COVID-19

Document Type : Case Report

Author

Maythem Abdulhassan Al Kaisy

Emergency Department, Al Ain Hospital, Al Ain, United Arab Emirates

https://doi.org/10.34172/jept.2021.11
Abstract
Objective: During the late 2019, a group of patients had unexplained chest infections in Wuhan which turned out to be the new pandemic coronavirus disease 2019 (COVID-19). New neurological symptoms have been reported in COVID-19 patients. Posterior reversible encephalopathy syndrome (PRES) is a new neurological finding and is associated or caused by COVID-19.
Case Presentation: A 32-year-old lady, with no medical background had COVID-19 infection and needed mechanical ventilation. After surviving the intensive care, she started to have multiple seizures that required general anesthesia to be aborted. The patient turned out to have PRES.
Conclusion: PRES is a neurological syndrome causing seizures, headaches, and blurred vision. It is usually associated with high blood pressure, renal failure, and other risk factors. The patient in this case had nearly normal blood pressure, but still had a diagnosis of PRES. The new reported neurological symptoms associated with COVID-19 infection need further research and attention from the academic society to predict and prevent the morbidity and mortality of COVID-19 patients.

Keywords

PRES
COVID-19
Seizure
Subjects
1. Eid M, Al-Kaisy M, Regeia W, Jiwa Khan H. The prognostic accuracy of neutrophil-lymphocyte ratio in COVID-19 patients. Front Emerg Med 2021;5(1):e8. doi:10.22114/ ajem.v0i0.472
2. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020;395(10224):565-574. doi:10.1016/ s0140-6736(20)30251-8
3. Divani AA, Andalib S, Di Napoli M, Lattanzi S, Hussain MS, Biller J, et al. Coronavirus disease 2019 and stroke: clinical manifestations and pathophysiological insights. J Stroke Cerebrovasc Dis 2020;29(8):104941. doi:10.1016/j. jstrokecerebrovasdis.2020.104941
4. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382(18):1708-1720. doi:10.1056/ NEJMoa2002032
5. Hinduja A. Posterior reversible encephalopathy syndrome: clinical features and outcome. Front Neurol 2020;11:71. doi:10.3389/fneur.2020.00071
6. Kaya Y, Kara S, Akinci C, Kocaman AS. Transient cortical blindness in COVID-19 pneumonia; a PRES-like syndrome: case report. J Neurol Sci 2020;413:116858. doi:10.1016/j. jns.2020.116858
7. Kishfy L, Casasola M, Banankhah P, Parvez A, Jan YJ, Shenoy AM, et al. Posterior reversible encephalopathy syndrome (PRES) as a neurological association in severe COVID-19. J Neurol Sci 2020;414:116943. doi:10.1016/j. jns.2020.116943
Journal of Emergency Practice and Trauma
Volume 7, Issue 2
July 2021
Pages 143-145

  • Receive Date 12 March 2021
  • Revise Date 20 April 2021
  • Accept Date 19 May 2021

Home

Editor-in-Chief: Shahrad Tajoddini, MD

Guide for Authors

Submit Manuscript

Reviewers

Contact Us

Editorial board